Efforts to treat sepsis faster have not resulted in antibiotic overuse Hospitals and policymakers alike have banded together to improve recognition and treatment of sepsis, a life-threatening reaction to infection, which by some estimates, accounts for 30–50% of all deaths in hospitalized patients. Lessening sepsis’ deadly effects means clinicians need to move quickly to recognize the signs and symptoms, and initiate treatment with antibiotics. However, a parallel movement

    Study identifies new DNA clues for Parkinson’s disease risk Findings of a new Parkinson’s disease study have opened an exciting avenue for developing therapeutics to intervene in the progression of this common movement disorder. The feature article in Experimental Biology and Medicine contributes to understanding of genetic processes underlying nerve cell degeneration in people with Parkinson’s. The study, led by Professor Sulev Koks at Western Australia’s Perron Institute for Neurological

    Monkeypox found to be evolving at a faster rate than expected   A team of researchers at the National Institute of Health Doutor Ricardo Jorge in Portugal, working with a colleague at Lusófona University, also in Portugal, has found that the monkeypox virus has been evolving at a faster rate than expected. In their paper published in the journal Nature Medicine, the researchers describe their genetic study of the